ModAstera has been selected as one of 15 finalists in the Qualcomm AI Program for Innovators (QAIPI) 2025 - APAC, receiving 6 months of mentorship and platform support to accelerate AI development.
By ModAstera
23 May 2025
We are thrilled to announce that ModAstera has been selected as one of 15 standout startups across Japan, Singapore, and Korea to participate in Qualcomm’s AI Program for Innovators (QAIPI) 2025!
The QAIPI 2025 – APAC is a competitive program launched by Qualcomm Technologies, aimed at empowering startups and individual developers across Asia-Pacific to build scalable, on-device AI solutions. We will receive through 6 months of 1:1 mentorship, direct access to Qualcomm’s hardware and platform expertise, and resources to bring cutting-edge products to market faster.
This recognition marks a significant milestone in our mission to transform medical AI with MAEA, the world’s first Medical AI Engineering Agent, built to automate and accelerate compliant AI development in healthcare.
🔗Learn more about the Qualcomm AI Program for Innovators here: :https://www.qualcomm.com/ai-program-for-innovators/apac
ModAstera and Wellgen Medical are partnering to build AI screening models for cancer cytology, combining FDA-cleared tomographic imaging, clinical datasets, and rapid medical AI deployment.
ModAstera welcomes Prof. Christian Aldridge, a leading UK dermatologist and skin cancer authority, as Chief Medical Officer to drive clinical governance across Hebra and MAEA.
ModAstera participated in the Qualcomm AI Program for Innovators (QAIPI) 2025 APAC Demo Day in Seoul, showcasing our vision for secure, privacy-preserving medical AI and deepening collaboration within the global AI ecosystem.
